<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00855777</url>
  </required_header>
  <id_info>
    <org_study_id>University of Verona - CE1597</org_study_id>
    <nct_id>NCT00855777</nct_id>
  </id_info>
  <brief_title>Etoricoxib Versus Ibuprofen in Third Molar Extraction Pain</brief_title>
  <official_title>Evaluation of Analgesic Efficacy of Etoricoxib Compared With Ibuprofen in Third Molar Extraction Pain.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universita di Verona</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universita di Verona</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to evaluate the analgesic efficacy of etoricoxib compared with a
      well known and widely used non-steroid antinflammatory drug, ibuprofen, in third molar
      extraction pain. At this time, there are no data about the efficacy of etoricoxib for
      reducing pain following dental extraction.

      This will be a single center, randomized, double-blind study, in which patients with moderate
      to severe pain following third molar extraction will be randomized to receive etoricoxib (120
      mg in a single dose + 2 dose of placebo pro day for 3 days) or ibuprofen (1800 mg in 3 doses
      pro day for 3 days). Paracetamol plus codeine will be used as rescue medication. Pain
      assessment will be performed using a 11-point pain intensity scale (0 = no pain and 10 =
      worster pain) during the first 3 days after dental extraction. Patients will be enrolled 15
      days before the dental extraction. During enrollment visit a complete clinical evaluation
      with particular attention for potential exclusion criteria (e.g. hypertension and
      cardiovascular risk factors) as well as blood analyses will be performed. A follow-up visit
      will be performed 15 days after the dental extraction. Tolerability will be assessed through
      recording of adverse events.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>April 2009</start_date>
  <completion_date type="Anticipated">April 2010</completion_date>
  <primary_completion_date type="Anticipated">December 2009</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>analgesic efficacy</measure>
    <time_frame>3 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>side effects</measure>
    <time_frame>3 days</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">110</enrollment>
  <condition>Dental Extraction</condition>
  <arm_group>
    <arm_group_label>Etoricoxib</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Etoricoxib 120 mg/day x 3 days</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ibuprofen</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Ibuprofen 1800 mg/day x 3 days</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>etoricoxib</intervention_name>
    <description>etoricoxib 120 mg/day for 3 days</description>
    <arm_group_label>Etoricoxib</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>ibuprofen</intervention_name>
    <description>ibuprofen 1,800 mg/day for 3 days</description>
    <arm_group_label>Ibuprofen</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  subjects with age &gt; 18 years

          -  in good health status (assessed in occasion of enrollment visit) without any major
             systemic illness

          -  candidate to third molar extraction and presenting local pain within 2 hours after
             dental extraction

        Exclusion Criteria:

          -  patients with any major systemic illness

          -  patients with a clinical history of drug abuse

          -  patients with hypertension and/or a condition of increased cardiovascular risk

          -  pregnant or lactating women

          -  patients with a history of hypersensitivity/allergy to analgesic drugs, including
             classical NSAID or coxibs

          -  patients with either high levels of liver enzymes (major of 1.5x the upper limit of
             reference interval) or of creatinine(major of 1.2x the upper limit of reference
             interval)

          -  patients with either a history of peptic ulcer or of haemorrhagic diathesis

          -  patients who can not ensure an adequate compliance for the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Roberto Corrocher, MD</last_name>
    <role>Study Director</role>
    <affiliation>Universita di Verona</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Roberto Corrocher, MD</last_name>
    <phone>+39-045-8124401</phone>
    <email>roberto.corrocher@univr.it</email>
  </overall_contact>
  <verification_date>March 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 3, 2009</study_first_submitted>
  <study_first_submitted_qc>March 3, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 4, 2009</study_first_posted>
  <last_update_submitted>March 3, 2009</last_update_submitted>
  <last_update_submitted_qc>March 3, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 4, 2009</last_update_posted>
  <responsible_party>
    <name_title>professor Roberto Corrocher</name_title>
    <organization>Department of Clinical and Experimental Medicine - University of Verona</organization>
  </responsible_party>
  <keyword>third molar extraction</keyword>
  <keyword>etoricoxib</keyword>
  <keyword>ibuprofen</keyword>
  <keyword>analgesic efficacy</keyword>
  <keyword>pain</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ibuprofen</mesh_term>
    <mesh_term>Etoricoxib</mesh_term>
    <mesh_term>Analgesics</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

